Study Title: A Phase II Randomized Trial of Adjuvant Therapy With Pembrolizumab After Resection of Recurrent/Second Primary Head and Neck Squamous Cell Carcinoma With High Risk Features
For more information about the trial above please contact the study team:Medical University of South CarolinaPrincipal Investigator, Harper, Jennifer, at harperjl@musc.edu.Study Coordinator, Avinger, Madison, at avingerm@musc.edu.Trial opened at the following institutions: Medical University of South Carolina